Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Joaquin Espinosa to Female

This is a "connection" page, showing publications Joaquin Espinosa has written about Female.

 
Connection Strength
 
 
 
0.412
 
  1. Donovan MG, Chillamcherla S, Enriquez Estrada BA, Worek KR, Sundararajan Z, Barstch KW, Sullivan KD, Galbraith MD, Rachubinski AL, Espinosa JM. Systematic multi-omic deconvolution of the clinical heterogeneity of Down syndrome. Nat Commun. 2026 May 11; 17(1).
    View in: PubMed
    Score: 0.033
  2. Eduthan NP, Donovan MG, Araya P, Rachubinski AL, Sullivan KD, Galbraith MD, Espinosa JM. An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. Nat Commun. 2025 Sep 24; 16(1):8346.
    View in: PubMed
    Score: 0.032
  3. Santoro JD, Eduthan NP, Khoshnood MM, Jafarpour S, Boyd NK, Vogel BN, Nguyen L, Kazerooni L, Britton E, Lyford HR, Galbraith MD, Rachubinski AL, Espinosa JM. Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression Disorder. Ann Clin Transl Neurol. 2025 04; 12(4):805-820.
    View in: PubMed
    Score: 0.031
  4. Rachubinski AL, Patel LR, Sannar EM, Kammeyer RM, Sanders J, Enriquez-Estrada BA, Worek KR, Fidler DJ, Santoro JD, Espinosa JM. JAK inhibition in Down Syndrome Regression Disorder. J Neuroimmunol. 2024 10 15; 395:578442.
    View in: PubMed
    Score: 0.030
  5. Donovan MG, Rachubinski AL, Smith KP, Araya P, Waugh KA, Enriquez-Estrada B, Britton EC, Lyford HR, Granrath RE, Schade KA, Kinning KT, Paul Eduthan N, Sullivan KD, Galbraith MD, Espinosa JM. Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome. Cell Rep. 2024 08 27; 43(8):114599.
    View in: PubMed
    Score: 0.030
  6. Donovan MG, Eduthan NP, Smith KP, Britton EC, Lyford HR, Araya P, Granrath RE, Waugh KA, Enriquez Estrada B, Rachubinski AL, Sullivan KD, Galbraith MD, Espinosa JM. Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome. Nat Commun. 2024 Jun 28; 15(1):5473.
    View in: PubMed
    Score: 0.029
  7. Pham AT, Rachubinski AL, Enriquez-Estrada B, Worek K, Griffith M, Espinosa JM. JAK inhibition for treatment of psoriatic arthritis in Down syndrome. Rheumatology (Oxford). 2021 09 01; 60(9):e309-e311.
    View in: PubMed
    Score: 0.024
  8. Sullivan KD, Galbraith MD, Kinning KT, Bartsch KW, Levinsky NC, Araya P, Smith KP, Granrath RE, Shaw JR, Baxter RM, Jordan KR, Russell SA, Dzieciatkowska ME, Reisz JA, Gamboni F, Cendali FI, Ghosh T, Monte AA, Bennett TD, Miller MG, Hsieh EW, D'Alessandro A, Hansen KC, Espinosa JM. The COVIDome Explorer researcher portal. Cell Rep. 2021 08 17; 36(7):109527.
    View in: PubMed
    Score: 0.024
  9. Waugh KA, Araya P, Pandey A, Jordan KR, Smith KP, Granrath RE, Khanal S, Butcher ET, Estrada BE, Rachubinski AL, McWilliams JA, Minter R, Dimasi T, Colvin KL, Baturin D, Pham AT, Galbraith MD, Bartsch KW, Yeager ME, Porter CC, Sullivan KD, Hsieh EW, Espinosa JM. Mass Cytometry Reveals Global Immune Remodeling with Multi-lineage Hypersensitivity to Type I Interferon in Down Syndrome. Cell Rep. 2019 11 12; 29(7):1893-1908.e4.
    View in: PubMed
    Score: 0.021
  10. Araya P, Waugh KA, Sullivan KD, Núñez NG, Roselli E, Smith KP, Granrath RE, Rachubinski AL, Enriquez Estrada B, Butcher ET, Minter R, Tuttle KD, Bruno TC, Maccioni M, Espinosa JM. Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity. Proc Natl Acad Sci U S A. 2019 11 26; 116(48):24231-24241.
    View in: PubMed
    Score: 0.021
  11. Fitzpatrick V, Noah A, Rivelli A, Johnson R, Zak M, Espinosa J, Chicoine B. Cancer Prevalence Among Large Cohort of Individuals With Down Syndrome: Implications for Screening Guidelines. Cancer Med. 2026 Jun; 15(6):e72007.
    View in: PubMed
    Score: 0.008
  12. Posey JN, Jordan M, Olsen-Dufour A, Nguyen TN, Farrell C, Lewis CV, Archambault JL, Sul C, Colon-Hidalgo D, Nozik ES, Espinosa JM, Sullivan KD, Delaney C. Interferon receptor gene dosage differentially regulates hypoxia-induced platelet activation and pulmonary hypertension in down syndrome. Front Immunol. 2026; 17:1832057.
    View in: PubMed
    Score: 0.008
  13. Lubkin A, Lujan RA, Pontejo SM, Oikonomou V, Fellows AM, Dos Santos Dias L, Snarr BD, MacAlpine J, Sullivan KD, Espinosa JM, Hickman H, Lionakis MS. The Dp16 Down syndrome mouse model does not exhibit oral interferon-gammopathy or susceptibility to oral candidiasis. mBio. 2026 03 11; 17(3):e0387325.
    View in: PubMed
    Score: 0.008
  14. Dunn LN, Niemeyer BF, Eduthan NP, Schade KA, Waugh KA, Brown C, Rachubinski AL, Timkovich AE, Orlicky DJ, Galbraith MD, Espinosa JM, Sullivan KD. Altered hepatic metabolism in Down syndrome. Cell Rep. 2026 Jan 27; 45(1):116835.
    View in: PubMed
    Score: 0.008
  15. Sillau SH, Coughlan C, Ahmed MM, Nair K, Araya P, Galbraith MD, Ritchie A, Ching-Jung Wang A, Elos MT, Bettcher BM, Espinosa JM, Chial HJ, Epperson N, Boyd TD, Potter H. Blood measure of neuronal death is exponentially higher with age, especially in females, and halted in Alzheimer's disease by GM-CSF treatment. Cell Rep Med. 2026 Jan 20; 7(1):102525.
    View in: PubMed
    Score: 0.008
  16. Feldman ER, Li Y, Cutler DJ, Rosser TC, Wechsler SB, Sanclemente L, Rachubinski AL, Elliott N, Vyas P, Roberts I, Rabin KR, Wagner M, Gelb BD, Espinosa JM, Lupo PJ, de Smith AJ, Sherman SL, Leslie-Clarkson EJ. Genome-Wide Association Studies of Down Syndrome Associated Congenital Heart Defects Suggests a Genetically Heterogeneous Risk for CHD in DS. Genet Epidemiol. 2025 06; 49(4):e70010.
    View in: PubMed
    Score: 0.008
  17. Barrachina-Esteve O, Anguita A, Reverter A, Espinosa J, Lafuente C, Rubio-Roy M, Crosas M, Vila-Sala C, Acero C, Navarro M, Cánovas D, Ribera G, Jodar M, Estela J. Neurologic features in hospitalized patients with COVID-19: a prospective cohort in a catalan hospital. Neurol Sci. 2025 Apr; 46(4):1477-1488.
    View in: PubMed
    Score: 0.008
  18. Gillenwater LA, Galbraith MD, Rachubinski AL, Eduthan NP, Sullivan KD, Espinosa JM, Costello JC. Integrated analysis of immunometabolic interactions in Down syndrome. Sci Adv. 2024 12 13; 10(50):eadq3073.
    View in: PubMed
    Score: 0.008
  19. Ryan S, Crowe L, Almeida Cruz SN, Galbraith MD, O'Brien C, Hammer JA, Bergin R, Kellett SK, Markey GE, Benson TM, Fagan O, Espinosa JM, Conlon N, Donohoe CL, McKiernan S, Hogan AE, McNamee EN, Furuta GT, Menard-Katcher C, Masterson JC. Metabolic dysfunction mediated by HIF-1a contributes to epithelial differentiation defects in eosinophilic esophagitis. J Allergy Clin Immunol. 2024 Dec; 154(6):1472-1488.
    View in: PubMed
    Score: 0.007
  20. Vita S, Di Bari V, Corpolongo A, Goletti D, Espinosa J, Petracca S, Palmieri F, Nicastri E. Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome. Int J Infect Dis. 2021 Feb; 103:607-610.
    View in: PubMed
    Score: 0.006
  21. Tuttle KD, Waugh KA, Araya P, Minter R, Orlicky DJ, Ludwig M, Andrysik Z, Burchill MA, Tamburini BAJ, Sempeck C, Smith K, Granrath R, Tracy D, Baxter J, Espinosa JM, Sullivan KD. JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome. Cell Rep. 2020 11 17; 33(7):108407.
    View in: PubMed
    Score: 0.006
  22. Deigendesch N, Hirsiger JR, Bigler MB, Ghosh A, Harder D, Jauch A, Espinosa JM, Recher M, Navarini A, Daikeler T, Berger CT. Tumoural soft tissue calcification in Down syndrome: association with heterozygous germline SAMD9 mutation and hyperactive type I interferon signaling. Rheumatology (Oxford). 2020 11 01; 59(11):e102-e104.
    View in: PubMed
    Score: 0.006
  23. Oliphant MUJ, Vincent MY, Galbraith MD, Pandey A, Zaberezhnyy V, Rudra P, Johnson KR, Costello JC, Ghosh D, DeGregori J, Espinosa JM, Ford HL. SIX2 Mediates Late-Stage Metastasis via Direct Regulation of SOX2 and Induction of a Cancer Stem Cell Program. Cancer Res. 2019 02 15; 79(4):720-734.
    View in: PubMed
    Score: 0.005
  24. Riera FL, Roldán JE, Espinosa JM, Fernandez JE, Ortiz I, Hinrichs K. Application of embryo biopsy and sex determination via polymerase chain reaction in a commercial equine embryo transfer program in Argentina. Reprod Fertil Dev. 2019 Jan; 31(12):1917-1925.
    View in: PubMed
    Score: 0.005
  25. Stoffel S, Benito L, Milà N, Travier N, Binefa G, Vidal C, Espinosa J, Moreno V, Garcia M. Testing behavioral interventions to optimize participation in a population-based colorectal cancer screening program in Catalonia, Spain. Prev Med. 2019 02; 119:58-62.
    View in: PubMed
    Score: 0.005
  26. Galati DF, Sullivan KD, Pham AT, Espinosa JM, Pearson CG. Trisomy 21 Represses Cilia Formation and Function. Dev Cell. 2018 09 10; 46(5):641-650.e6.
    View in: PubMed
    Score: 0.005
  27. Guarnieri AL, Towers CG, Drasin DJ, Oliphant MUJ, Andrysik Z, Hotz TJ, Vartuli RL, Linklater ES, Pandey A, Khanal S, Espinosa JM, Ford HL. The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L. Oncogene. 2018 07; 37(28):3879-3893.
    View in: PubMed
    Score: 0.005
  28. Fitzwalter BE, Towers CG, Sullivan KD, Andrysik Z, Hoh M, Ludwig M, O'Prey J, Ryan KM, Espinosa JM, Morgan MJ, Thorburn A. Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover. Dev Cell. 2018 03 12; 44(5):555-565.e3.
    View in: PubMed
    Score: 0.005
  29. Sullivan KD, Evans D, Pandey A, Hraha TH, Smith KP, Markham N, Rachubinski AL, Wolter-Warmerdam K, Hickey F, Espinosa JM, Blumenthal T. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci Rep. 2017 11 01; 7(1):14818.
    View in: PubMed
    Score: 0.005
  30. Carmona-Bayonas A, Jiménez-Fonseca P, Virizuela J, Antonio M, Font C, Biosca M, Ramchandani A, Martinez-Garcia J, Hernando J, Espinosa J, de Castro EM, Ghanem I, Beato C, Blasco A, Garrido M, Mondéjar R, Arcusa MÁ, Aragón I, Manzano A, Sevillano E, Castañón E, Ayala F. Performance of the clinical index of stable febrile neutropenia (CISNE) in different types of infections and tumors. Clin Transl Oncol. 2017 Mar; 19(3):386-395.
    View in: PubMed
    Score: 0.004
  31. Tentler JJ, Ionkina AA, Tan AC, Newton TP, Pitts TM, Glogowska MJ, Kabos P, Sartorius CA, Sullivan KD, Espinosa JM, Eckhardt SG, Diamond JR. p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer. Mol Cancer Ther. 2015 May; 14(5):1117-29.
    View in: PubMed
    Score: 0.004
  32. Alvarez-Lerma F, Soriano MC, Rodríguez M, Catalán M, Llorente AM, Vidart N, Garitacelaya M, Maraví E, Fernández E, Alvarado F, López M, Alvarez-Sánchez B, Espinosa J, Quintana E. Impact of liposomal amphotericin B on renal function in critically ill patients with renal function impairment. Rev Esp Quimioter. 2012 Sep; 25(3):206-15.
    View in: PubMed
    Score: 0.003
  33. Brewer GJ, Espinosa J, McIlhaney MP, Pencek TP, Kesslak JP, Cotman C, Viel J, McManus DC. Culture and regeneration of human neurons after brain surgery. J Neurosci Methods. 2001 May 30; 107(1-2):15-23.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)